KU-55933 Chemical Structure
KU-60019 is a specific improved ATM kinase inhibitor.
CP-466722 is rapidly reversible potential ATM kinase inhibitor.
BEZ235 (NVP-BEZ235)is a dual ATP-competitive phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) inhibitor of p110α, p110γ, p110δ and p110β with IC50 of 4 nM, 5 nM, 7 nM and 75 nM,respectively.
Deforolimus (Ridaforolimus) is a small-molecule inhibitor of mTOR.
Perifosine is an Akt inhibitor. the antiproliferative properties of perifosine with an IC50 of 0.6–8.9 µM.
PI-103 is a potent, cell-permeable, ATP-competitive PI3K family member inhibitor with IC50 of 2, 8, 20, 26, 48, 83, 88, 150 nM for DNA-PK, p110α, mTORC1, PI3-KC2β, p110δ, mTORC2, p110β, and p110γ, respectively.
Rapamycin also known as Sirolimus & Rapamune is an mTOR inhibitor. Rapamycin Sirolimus inhibits cell motility by suppression of mTOR-mediated pathways.
Temsirolimus (Torisel) is a mTOR inhibitor.
Inhibitor of Class I PI3 Kinase,p110a IC50=0.003uM,U87MG IC50=0.95μM.
ZSTK474 is an inhibitor of PI3K γ(IC50 at 6 nM).
KU-55933 is a potent ATM inhibitor with an IC50 and a Ki of 13 and 2.2 nM, respectively. KU-55933 shows specificity with respect to inhibition of other phosphatidylinositol 3-kinase–like kinases. Exposure of cells to KU-55933 resulted in a significant sensitization to the cytotoxic effects of ionizing radiation and to the DNA double-strand break-inducing chemotherapeutic agents, etoposide, doxorubicin, and camptothecin. Derivatives of this molecule may serve as novel radio- and chemosensitizors in clinical settings. [1][2]
| Molecular Weight (WM): | 395.49 |
|---|---|
| Formula: | C21H17NO3S2 |
| CAS No.: | 587871-26-9 |
| Synonyms: |
N/A
|
| Dissolve in (25°C): | DMSO ≥50mg/mL |
| Water <1mg/mL | |
| Ethanol ≥13mg/mL | |
| Storage: | 2 years-20°CPowder |
| 1 week-4°Cin DMSO | |
| 1 month-80°in DMSO |
A collection of 864 bioactive compounds
A collection of 481 inhibitors
A collection of 194 kinase inhibitors
A collection of 85 tyrosine kinase inhibitors.
A collection of 426 FDA approved drugs
A collection of 139 natural products
A collection of 40 chemotherapeutic agents
A unique collection of 17 small molecule modulators
A unique collection of 47 small molecule inhibitors
A unique collection of 63 GPCR small molecules

effect of ATM inhibitor in etoposide-induced cell death. The cells were pretreated with KU55933 (2 M) for 1 h before etoposide treatment.
|
effect of ATM inhibitor in etoposide-induced cell death. The cells were pretreated with KU55933 (2 M) for 1 h before etoposide treatment.
Data from [Journal of Biological Chemistry 2011.March;286:8394-8404] KU-55933 purchased from Selleck

Renkuo LinUniversity of Medicine and Dentistry of New Jersey

Meng, XiangbingThe University of Iowa

Coby Meijer PhDUniversity Medical Center Groningen Medische Oncologie, Lab. MOL “de Vitrine”Groningen
Keywords:buy KU-55933 | KU-55933 supplier | purchase KU-55933 | KU-55933 cost | KU-55933 manufacturer | order KU-55933 | KU-55933 distributor